A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen

Clinical Nephrology

Volumn 70, Issue 2, 2008, Pages 172-175

  Costanzi, Stefano ^a,b   Zoli, A ^a   Ferraro, P M ^a   Danza, F M ^a   Ferraccioli, G F ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UCSC Allergy Unit   (Italy)

Author keywords

Corticosteroid resistance; Paraneoplastic retroperitoneal fibrosis; Tamoxifen

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CREATININE; PREDNISONE; TAMOXIFEN;

AGED; ANAMNESIS; ANEMIA; ARTICLE; CANCER SURGERY; CASE REPORT; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; ECHOGRAPHY; FEVER; HEMATURIA; HISTOPATHOLOGY; HUMAN; HYDRONEPHROSIS; KIDNEY CARCINOMA; KIDNEY SURGERY; MALAISE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEAL BIOPSY; RETROPERITONEAL FIBROSIS; STENT; URETER OBSTRUCTION; URINALYSIS;

EID: 48749089248     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp70172     Document Type: Article

References (10)

1. Benson JR, Baum M. Tamoxifen for retroperitoneal fibrosis. Lancet 1993; 341: 836.
2. Connolly J, Eisner D, Goldman S, Stutzman R, Steiner M. Benign retroperitoneal fibrosis and renal cell carcinoma. J Urol. 1993; 149: 1535-1537.
3. Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Vanenti L, Ferretti S, Corbelli R, Moroni G, Dei Tos AP, Buzio C, Vaglio A. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int. 2007; 72: 742-753.
4. del Peso G, Bajo MA, Gil F, Aguilera A, Ros S, Costero O, Castro MJ, Selgas R. Clinical experience with tamoxifen in peritoneal fibrosing syndromes. Adv Perit Dial. 2003; 19: 32-35.
5. Eltoum MA, Wright S, Atchley J, Mason JC. Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int. 2006; 26: 203-206.
6. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer. 2004; 100: 612-620.
7. Horgan K, Cooke E, Hallett MB, Mansel RE. Inhibition of protein kinase C-mediated signal transduction by tamoxifen: importance for antitumor activity. Biochem Pharmacol. 1986; 35: 4463-4465.
8. Moroni G, Gallelli B, Banfi G, Sandri S, Messa P, Ponticelli C. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. Nephrol Dial Transplant. 2006; 21: 2485-2490.
9. Van Bommel EF, Hendriksz TR, Huiskes AW, Zeegers AG. Tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med. 2006; 144: 101-106.
10. Van Bommel EF. Retroperitoneal fibrosis. Neth J Med. 2002; 60: 231-249.